Kennedy Capital Management LLC boosted its holdings in shares of TriMas Co. (NASDAQ:TRS - Free Report) by 94.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 485,721 shares of the industrial products company's stock after buying an additional 236,346 shares during the period. Kennedy Capital Management LLC owned approximately 1.20% of TriMas worth $11,944,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also recently bought and sold shares of TRS. FMR LLC boosted its position in TriMas by 1.7% during the third quarter. FMR LLC now owns 44,082 shares of the industrial products company's stock valued at $1,125,000 after purchasing an additional 729 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in TriMas by 3.3% in the third quarter. JPMorgan Chase & Co. now owns 38,461 shares of the industrial products company's stock worth $982,000 after buying an additional 1,227 shares during the last quarter. First Eagle Investment Management LLC raised its position in TriMas by 1.8% during the fourth quarter. First Eagle Investment Management LLC now owns 257,506 shares of the industrial products company's stock valued at $6,332,000 after acquiring an additional 4,500 shares in the last quarter. Wells Fargo & Company MN lifted its stake in TriMas by 21.1% in the fourth quarter. Wells Fargo & Company MN now owns 37,729 shares of the industrial products company's stock valued at $928,000 after acquiring an additional 6,573 shares during the last quarter. Finally, American Century Companies Inc. grew its position in TriMas by 11.2% in the fourth quarter. American Century Companies Inc. now owns 78,876 shares of the industrial products company's stock worth $1,940,000 after acquiring an additional 7,938 shares in the last quarter. 99.42% of the stock is currently owned by institutional investors and hedge funds.
TriMas Stock Performance
TRS traded down $0.49 on Tuesday, hitting $20.51. The company had a trading volume of 92,976 shares, compared to its average volume of 303,783. The stock has a market cap of $835.09 million, a price-to-earnings ratio of 32.05 and a beta of 0.55. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44. The company's fifty day moving average price is $22.97 and its 200 day moving average price is $24.67. TriMas Co. has a 1-year low of $19.33 and a 1-year high of $28.51.
TriMas Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 28th were issued a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a dividend yield of 0.78%. The ex-dividend date of this dividend was Friday, February 28th. TriMas's dividend payout ratio is currently 27.12%.
Wall Street Analyst Weigh In
Separately, BWS Financial reaffirmed a "buy" rating and issued a $40.00 price objective on shares of TriMas in a research note on Friday, February 28th.
Get Our Latest Stock Report on TRS
Insider Buying and Selling
In other news, CFO Scott A. Mell sold 2,218 shares of the stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $22.54, for a total value of $49,993.72. Following the completion of the sale, the chief financial officer now directly owns 26,288 shares of the company's stock, valued at approximately $592,531.52. This represents a 7.78 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jeffrey A. Fielkow bought 2,500 shares of the company's stock in a transaction that occurred on Friday, February 28th. The shares were bought at an average cost of $20.78 per share, for a total transaction of $51,950.00. Following the transaction, the director now directly owns 11,013 shares of the company's stock, valued at $228,850.14. This trade represents a 29.37 % increase in their position. The disclosure for this purchase can be found here. Insiders have bought 806,246 shares of company stock worth $19,338,213 in the last quarter. 1.10% of the stock is currently owned by company insiders.
About TriMas
(
Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Featured Stories

Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.